The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation

This publication has 78 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Depolarization of In Situ Mitochondria Due to Hydrogen Peroxide‐Induced Oxidative Stress in Nerve Terminals
  Journal of Neurochemistry, 1999
• Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
• Bioenergetic and oxidative stress in neurodegenerative diseases
  Life Sciences, 1995
• In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Mechanism of the neurotoxicity of MPTP
  FEBS Letters, 1990
• 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
  Biochemical and Biophysical Research Communications, 1990
• Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone
  Biochemical and Biophysical Research Communications, 1990
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+
  Biochemical and Biophysical Research Communications, 1986
• Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (NMPTP) in mouse brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984